W STRATEGIES, LLC

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Lobbying activity 1

Medicare/Medicaid

Monitored Public Law 119-21: One Big Beautiful Bill Act. Issues related to drug pricing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.